Skip to content
Menu
English
Menu
Company
Company Overview
Milestones
Technologies
Management Team
Board of Directors
Clinical Advisory Board
Events
Careers
News
Healthcare Professionals
Solutions
COPD/ Emphysema
Products
FreeFlow
®
Coil #2 System
FreeFlow
®
Coil #4 System
Clinical Evidence
Coil Technology Clinical Evidence
Training Program
Events
Patients
About Asthma, COPD/Emphysema
About severe Emphysema
About FreeFlow
®
Coil Therapy
Contact
Menu
Company
Company Overview
Milestones
Technologies
Management Team
Board of Directors
Clinical Advisory Board
Events
Careers
News
Healthcare Professionals
Solutions
COPD/ Emphysema
Products
FreeFlow
®
Coil #2 System
FreeFlow
®
Coil #4 System
Clinical Evidence
Coil Technology Clinical Evidence
Training Program
Events
Patients
About Asthma, COPD/Emphysema
About severe Emphysema
About FreeFlow
®
Coil Therapy
Contact
Timeline Stories
Category:
Timeline Stories
All timeline stories.
Home
»
Timeline Stories
FreeFlow® Coil #2 launched in Europe
Home
»
Timeline Stories
Free Flow Medical was incorporated
Home
»
Timeline Stories
Filed first patents
Home
»
Timeline Stories
Established Clinical Advisory Team
Home
»
Timeline Stories
Started GLP Animal Studies
Home
»
Timeline Stories
Filed IP for 2nd technology
Home
»
Timeline Stories
Reimbursement for Coil technology in Germany established
Home
»
Timeline Stories
Submitted Tech File for the FreeFlow® Coil System
Home
»
Timeline Stories
Free Flow Medical GmbH was formed
Home
»
Timeline Stories
CE Mark granted for FreeFlow® Coil portfolio
Older posts
Page
1
Page
2
Next
→
For more information about the
FreeFlow
®
Coil System
Contact us
Home
Company
Company Overview
Milestones
Technologies
Management Team
Board of Directors
Clinical Advisory Board
Events
Careers
News
Healthcare Professionals
Solutions
COPD/ Emphysema
Products
FreeFlow
®
Coil #4 System
Clinical Evidence
Coil Technology Clinical Evidence
Training Program
Events
Patients
About Asthma, COPD/Emphysema
About severe Emphysema
About FreeFlow
®
Coil Therapy
Contact
English
Close
